Main Menu

Breast Cancer Immunology Group 

The Breast Cancer Immunology group is led by Alan Melcher and looks at ways to activate the immune system to attack breast cancer using therapeutic oncolytic viruses, radiotherapy, targeted drugs and combination strategies. The agents we prioritise are already in clinical use and offer major potential benefits to further improve the promising field of immunotherapy.

The Breast Cancer Immunology group collaborates extensively with the Cancer Dynamics group.

Group leader

Professor Alan Melcher

Professor Alan Melcher

Professor Melcher is a clinician scientist studying how to activate the immune system to recognise and attack cancer. In particular, he works on oncolytic, anti-cancer viruses, which work mainly as a type of immunotherapy, and is a specialist in melanoma and head and neck cancer.

ORCID 0000-0002-2042-3380

Group members

Ernesto Lopez

Postdoctoral Training Fellow

Dr Nicolas Sarbia

Postdoctoral Training Fellow